Dorman Products, Inc. New (DORM) is a publicly traded Consumer Cyclical sector company. As of May 21, 2026, DORM trades at $117.14 with a market cap of $3.44B and a P/E ratio of 18.62. DORM moved +3.76% today. Year to date, DORM is -6.73%; over the trailing twelve months it is -10.33%. Its 52-week range spans $98.45 to $166.89. Analyst consensus is strong buy with an average price target of $149.33. Rallies surfaces DORM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Dorman Products’ EPS Outlook Slashed 4-9%, Roth Cuts Target 11% to $162: Roth Capital reduced its price target on Dorman Products by 11% to $162 while maintaining a Buy rating after Q4 adjusted EPS of $2.17 topped consensus $2.12. Management projected FY26 revenue growth of 7-9% but guided diluted EPS down 4-9% to $8.10-$8.50 versus $9.44 estimates.
| Metric | Value |
|---|---|
| Price | $117.14 |
| Market Cap | $3.44B |
| P/E Ratio | 18.62 |
| EPS | $6.24 |
| Dividend Yield | 1.50% |
| 52-Week High | $166.89 |
| 52-Week Low | $98.45 |
| Volume | 1 |
| Avg Volume | 0 |
| Revenue (TTM) | $2.15B |
| Net Income | $190.24M |
| Gross Margin | 40.91% |
6 analysts cover DORM: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $149.33.